Volume 15 (2017): Issue 12 (Dec 2017)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
Reviewer Page
Pages: xxxvi
NCCN News
Pages: xxxviii–lvii
Oncology Research Program
Pages: lxiii
It's About Time!
By: Margaret Tempero
Pages: 1443
Behavioral Economics and the Future of Biosimilars
By: Chadi Nabhan and Bruce A. Feinberg
Pages: 1449–1451
Champions Rising to the Challenge of Ensuring High-Quality Cancer Care
By: Katy Winckworth-Prejsnar, Elizabeth A. Nardi, and James McCanney
Pages: 1452–1454
Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification
By: Fiona Tsui-Fen Cheng, Fu Ou-Yang, Nina Lapke, Kai-Che Tung, Yen-Kung Chen, Yuh-Yu Chou, and Shu-Jen Chen
Pages: 1456–1459
Ensuring Patient Safety and Access in Cancer Care
By: Katy Winckworth-Prejsnar, Elizabeth A. Nardi, James McCanney, F. Marc Stewart, Terry Langbaum, Bruce J. Gould, C. Lyn Fitzgerald, and Robert W. Carlson
Pages: 1460–1464
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017
By: Samir Gupta, Dawn Provenzale, Scott E. Regenbogen, Heather Hampel, Thomas P. Slavin Jr, Michael J. Hall, Xavier Llor, Daniel C. Chung, Dennis J. Ahnen, Travis Bray, Gregory Cooper, Dayna S. Early, James M. Ford, Francis M. Giardiello, William Grady, Amy L. Halverson, Stanley R. Hamilton, Jason B. Klapman, David W. Larson, Audrey J. Lazenby, Patrick M. Lynch, Arnold J. Markowitz, Robert J. Mayer, Reid M. Ness, Niloy Jewel Samadder, Moshe Shike, Shajanpeter Sugandha, Jennifer M. Weiss, Mary A. Dwyer, and Ndiya Ogba
Pages: 1465–1475
External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancer
By: Erin R. Weeda, Jonathan T. Caranfa, Simon B. Zeichner, Craig I. Coleman, Elaine Nguyen, and Christine G. Kohn
Pages: 1476–1482
KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010–2013
By: Mary E. Charlton, Amanda R. Kahl, Alissa A. Greenbaum, Jordan J. Karlitz, Chi Lin, Charles F. Lynch, and Vivien W. Chen
Pages: 1484–1493
Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States
By: Benjamin H. Kann, Henry S. Park, Skyler B. Johnson, Veronica L. Chiang, and James B. Yu
Pages: 1494–1502
Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders
By: Daniel C. McFarland, Kelly M. Shaffer, Heather Polizzi, John Mascarenhas, Marina Kremyanskaya, Jimmie Holland, and Ronald Hoffman
Pages: 1503–1508
Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D
By: John A. Charlson, Emily L. McGinley, Ann B. Nattinger, Joan M. Neuner, and Liliana E. Pezzin
Pages: 1509–1517
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
By: Jeffrey Crawford, Pamela Sue Becker, James O. Armitage, Douglas W. Blayney, Julio Chavez, Peter Curtin, Shira Dinner, Thomas Fynan, Ivana Gojo, Elizabeth A. Griffiths, Shannon Hough, Dwight D. Kloth, David J. Kuter, Gary H. Lyman, Mary Mably, Sudipto Mukherjee, Shiven Patel, Lia E. Perez, Adam Poust, Raajit Rampal, Vivek Roy, Hope S. Rugo, Ayman A. Saad, Lee S. Schwartzberg, Sepideh Shayani, Mahsa Talbott, Saroj Vadhan-Raj, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, Jennifer L. Burns, and Lenora Pluchino
Pages: 1520–1541
A Patient Risk Model of Chemotherapy-Induced Febrile Neutropenia: Lessons Learned From the ANC Study Group
By: Gary H. Lyman and Marek S. Poniewierski
Pages: 1543–1550
Controversies Regarding Use of Myeloid Growth Factors in Leukemia
By: Jacqueline N. Poston and Pamela S. Becker
Pages: 1551–1557
Disparities in Adjuvant Endocrine Therapy
By: Elizabeth J. Cathcart-Rake and Kathryn J. Ruddy
Pages: 1559–1561
  • Collapse
  • Expand